---
title: "Ultrahuman’s $70M at $365M: Smart Rings Become On-Finger Computers"
description: "Qualcomm Ventures joined Ultrahuman’s $70M round ($65M equity + $5M debt) at a $365M valuation — betting rings can run software, AI, and games on-device, not only sleep metrics."
date: 2026-09-04T00:00:00.000Z
tags: ["2026-vc-news", "startup-funding", "venture-capital", "wearables", "healthtech", "india-vc"]
source: https://venturecapitaltracker.com/2026-ultrahuman-70m-365m-qualcomm
---

# Ultrahuman’s $70M at $365M: Smart Rings Become On-Finger Computers

> Qualcomm Ventures joined Ultrahuman’s $70M round ($65M equity + $5M debt) at a $365M valuation — betting rings can run software, AI, and games on-device, not only sleep metrics.

**Ultrahuman** raised **$70 million** on **September 3, 2026** — **$65 million** equity plus **$5 million** debt — at a **$365 million** valuation, about **3×** its **$120 million** 2023 mark (TechCrunch interview with CEO Mohit Kumar). **Qualcomm Ventures** and **Labcorp** joined Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital.

**Spine:** rings that only track sleep are commodities; rings that run software and AI on-finger are a platform bet — and Ultrahuman already claims **~$140M** revenue run rate.

## Key facts

| Field | Detail |
| --- | --- |
| Company | [Ultrahuman](/startup/ultrahuman) (Bengaluru) |
| Round | **$70M** ($65M equity + $5M debt) |
| Valuation | **$365M** |
| Notable | Qualcomm Ventures, Labcorp |
| ARR run rate | **~$140M** (company); targeting **~$200M** by Jan 2027 |
| Units | **~800k** rings sold |
| Founded | 2019 (Mohit Kumar, Vatsal Singhal) |

## Who uses the product — and for what job

**Users:** consumers buying Ring Air / Ring Pro for metabolic, sleep, and recovery tracking — with a growing cohort paying for PowerPlugs software (~12% of users).

**Job today:** continuous personal health sensing without a watch form factor.  
**Job next:** on-device compute for AI interactions, game control, pointing, and car-key style ambient interfaces — using finger placement plus biometrics.

U.S. is ~45% of revenue this quarter; India ~11%. Demand for Ring Pro in the U.S. is running **18–20× supply** after a patent-driven Ring Air pause (company via TechCrunch).

## Why now

- Oura is IPO-pathing; Ultrahuman is choosing **hardware + software platform** expansion over an immediate listing.
- Qualcomm silicon partnership points to rings that are less phone/cloud dependent.
- Labcorp explores pairing ring blood-flow signals with lab diagnostics — a path from wellness gadget to clinical adjacency.

## Why Qualcomm / Labcorp — portfolio fit

Qualcomm Ventures wants **personal AI device** surfaces beyond phones. Labcorp wants longitudinal wearable data married to diagnostics. Neither needs to lead a consumer hardware round to extract strategic optionality.

**Likely founder rationale:** raise enough to fix U.S. supply, fund retail in India/UAE, and finance silicon/clinical work — accepting near-term profitability tradeoffs — without racing Oura to a public ticker.

We do **not** invent `/fund/` links for Qualcomm Ventures or Labcorp.

| Dimension | Fit |
| --- | --- |
| Stage | Growth hardware + subscription |
| Thesis | Ring as computer, not tracker |
| Risk | Patent/IP fights, supply, Oura brand gravity, margin pressure from retail |

## Competitive map

| Player | Lane |
| --- | --- |
| Oura | Category leader; IPO-tracked |
| Smartwatches | Broader compute, worse continuous finger form factor |
| Other ring startups | Feature competition at lower scale |

## Takeaway

The interesting ratio is **~$140M ARR run rate on a $365M mark** — hardware multiples look disciplined if the software attach and clinical partnerships land. The unresolved issue: can Ultrahuman turn Qualcomm-era silicon into developer distribution before Oura’s public markets story freezes category mindshare?

### Sources

1. TechCrunch: https://techcrunch.com/2026/09/03/qualcomm-backs-ultrahuman-in-70m-round-on-bet-to-turn-smart-rings-into-computers/

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.